RNA Technology Driving the New Wave of Therapeutics, 2018 Market Report - ResearchAndMarkets.com

September 26, 2018

DUBLIN--(BUSINESS WIRE)--Sep 26, 2018--The “RNA Technology Driving the New Wave of Therapeutics” report has been added to ResearchAndMarkets.com’s offering.

This Drug Discovery TOE depicts trends across RNA technology driving a new wave of therapeutics. Different, stable, non-Immunogenic mRNA therapies, targeted RNAi technologies and therapeutics, CAR T-cell therapy, antisense therapeutics, RNA-based delivery platforms, and DNA-directed RNAi approaches are discussed in the TOE. Clinical trials of HIV vaccines is also depicted.

Key Topics Covered:

Innovations in Drug Discovery and Development

Targeted RNAi Technology for Enhanced Disease Management Developing Stable and Non-immunogenic mRNA Therapies Enabling Potent Antisense Therapeutics Fueling Novel RNA Therapy and Delivery Platforms Enabling Targeted Delivery of RNAi Therapeutics Positive Interim Data from Clinical Study of RNA-based Treatment Long-term Expression Using DNA-directed RNAi Approach Improving Immunotherapy by Enhancing CAR T-cell Therapy RNAi Drug Enters Clinical Study for Scar Reduction and Bile Duct Cancer

Drug Discovery Technology Focus and Trends

Clinical Trial Analysis Industry Interactions

For more information about this report visit https://www.researchandmarkets.com/research/xwhm74/rna_technology?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180926005896/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Genomics



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/26/2018 02:26 PM/DISC: 09/26/2018 02:26 PM


Update hourly